The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.
Open accessAbstract
A central issue in stem cell biology is to understand the mechanisms that regulate the self-renewal of haematopoietic stem cells (HSCs), which are required for haematopoiesis to persist for the lifetime of the animal. We found that adult and fetal mouse and adult human HSCs express the proto-oncogene Bmi-1. The number of HSCs in the fetal liver of Bmi-1-/- mice was normal. In postnatal Bmi-1-/- mice, the number of HSCs was markedly reduced. Transplanted fetal liver and bone marrow cells obtained from Bmi-1-/- mice were able to contribute only transiently to haematopoiesis. There was no detectable self-renewal of adult HSCs, indicating a cell autonomous defect in Bmi-1-/- mice. A gene expression analysis revealed that the expression of stem cell associated genes, cell survival genes, transcription factors, and genes modulating proliferation including p16Ink4a and p19Arf was altered in bone marrow cells of the Bmi-1-/- mice. Expression of p16Ink4a and p19Arf in normal HSCs resulted in proliferative arrest and p53-dependent cell death, respectively. Our results indicate that Bmi-1 is essential for the generation of self-renewing adult HSCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Upregulation of p16 and Arf has been implicated in mediating the induction of cellular senescence in a variety of cells including HSCs.”
From Total body irradiation causes long-term mouse BM injury via induction of HSC premature senescence in an Ink4a- and Arf-independent manner (2014) · cites this paper as [15]
In the citing paper
“However, it appears that p16, but not Arf, plays an important role in mediating induction of Bmi1−/− HSC senescence, whereas Arf mainly promotes HSC apoptosis.15”
From Total body irradiation causes long-term mouse BM injury via induction of HSC premature senescence in an Ink4a- and Arf-independent manner (2014) · cites this paper as [15]
In the citing paper
“For example, increased expression of p16 and Arf was found in HSCs from Bmi1−/− mice.15”
From Total body irradiation causes long-term mouse BM injury via induction of HSC premature senescence in an Ink4a- and Arf-independent manner (2014) · cites this paper as [15]
In the citing paper
“ROS plays an important role in mediating induction of HSC senescence under various pathological conditions, such as mutation of ATM and various Fanconi anemia genes; deletion of Bmi1, FoxOs, Mdm2, and Tsc1; and aging.15,19,20,35-38”
From Total body irradiation causes long-term mouse BM injury via induction of HSC premature senescence in an Ink4a- and Arf-independent manner (2014) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,267
"Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells
Ramalho‐Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R. C., & Melton, D. A. (2002) · Science · doi:10.1126/science.1072530 · Cited by 1,711
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Jacobs, J. J. L., Kieboom, K., Marino, S., DePinho, R. A., & van Lohuizen, M. (1999) · Nature · doi:10.1038/16476 · Cited by 1,580
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells.
Lessard, J., & Sauvageau, G. (2003) · Nature · doi:10.1038/nature01572 · Cited by 1,452
Hematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1
Cheng, T., Rodrigues, N., Shen, H., Yang, Y.-G., Dombkowski, D., Sykes, M., & Scadden, D. T. (2000) · Science · doi:10.1126/science.287.5459.1804 · Cited by 1,339
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206 · cited 1×
“Analysis of genes expressed in HSCs identified Bmi-1 , a member of the Polycomb Group ( PcG ) family linked to malignant transformation, lymphocyte development, neurological development and senescence of fibroblast”
BackgroundMorrison, S. J., & Weissman, I. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90037-x · Cited by 1,116
Self-citationNucleolar Arf sequesters Mdm2 and activates p53
Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., & Bar-Sagi, D. (1999) · Nature Cell Biology · doi:10.1038/8991 · Cited by 940
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 901–1,000 of 1,002
Bmi1 reprograms CML B-lymphoid progenitors to become B-ALL–initiating cells
Sengupta, A., Ficker, A. M., Dunn, S. K., Madhu, M., & Cancelas, J. A. (2011) · Blood · doi:10.1182/blood-2011-06-359232 · Cited by 35
Stem Cell: Past, Present and Future- A Review Article
Avasthi, S., Srivastava, R. N., & Singh, A. (2008) · Internet Journal of Medical Update - EJOURNAL · doi:10.4314/ijmu.v3i1.39856 · Cited by 38
Reactive oxygen species in BCR-ABL1-expressing cells – relevance to chronic myeloid leukemia
Antoszewska-Smith, J., Pawłowska, E., & Błasiak, J. (2016) · Acta Biochimica Polonica · doi:10.18388/abp.2016_1396 · Cited by 36
Liu, J., Li, C., Zhang, L., Liu, K., Jiang, X., Wang, X., Yang, L., Liang, W., Liu, K., Hu, J., et al. (2019) · Diagnostic Pathology · doi:10.1186/s13000-019-0834-0 · Cited by 34
Kobayashi, I., Ono, H., Moritomo, T., Kano, K., Nakanishi, T., & Suda, T. (2009) · Blood · doi:10.1182/blood-2009-07-232322 · Cited by 34
Epigenome programming by Polycomb and Trithorax proteins
Cernilogar, F. M., & Orlando, V. (2005) · Biochemistry and Cell Biology · doi:10.1139/o05-040 · Cited by 34
Shaw, P., Bhowmik, A. D., Pillai, M. S. G., Robbins, N., Dwivedi, S. K. D., & Rao, G. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217750 · Cited by 36
Switches, Excitable Responses and Oscillations in the Ring1B/Bmi1 Ubiquitination System
Nguyen, L. K., Muñoz-García, J., Maccario, H., Ciechanover, A. J., Kölch, W., & Kholodenko, B. Ν. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002317 · Cited by 35
Kitson, S., Rosser, M., Fischer, D. P., Marshall, K. M., Clarke, R. B., & Crosbie, E. J. (2019) · Cancers · doi:10.3390/cancers11050653 · Cited by 33
Bmi1 Promotes Erythroid Development Through Regulating Ribosome Biogenesis
Gao, R., Chen, S., Kobayashi, M., Yu, H., Zhang, Y., Wan, Y., Young-Baird, S. K., Soltis, A. R., Yu, M., Vemula, S., et al. (2014) · Stem Cells · doi:10.1002/stem.1896 · Cited by 36
Li, S., & Li, D. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00108.x · Cited by 34
Transcription factor Zfx controls BCR-induced proliferation and survival of B lymphocytes
Arenzana, T. L., Smith-Raska, M., & Reizis, B. (2009) · Blood · doi:10.1182/blood-2008-11-188888 · Cited by 33
Gudmundsson, K. O., Thorsteinsson, L., Sigurjónsson, Ó. E., Keller, J. R., Olafsson, K., EGELAND, T., Guðmundsson, S., & Rafnar, Þ. (2007) · Stem Cells · doi:10.1634/stemcells.2005-0479 · Cited by 33
Disruption of E2F signaling suppresses the INK4a-induced proliferative defect in M33-deficient mice
Coré, N., Joly, F., Boned, A., & Djabali, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207998 · Cited by 35
Loizou, J. I., Oser, G., Shukla, V., Sawan, C., Murr, R., Wang, Z., Trumpp, A., & Herceg, Z. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901969 · Cited by 37
Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis.
Zhang, X., Wang, C., Zhu, C., Zhang, J., Kan, S., Du, L., Li, W., Wang, L., & Wang, S. (2010) · PubMed · Cited by 33
Styczyński, J., & Drewa, T. A. (2007) · Acta Biochimica Polonica · doi:10.18388/abp.2007_3140 · Cited by 33
Transient requirements of YY1 expression for PcG transcriptional repression and phenotypic rescue
Srinivasan, L., Pan, X., & Atchison, M. L. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20562 · Cited by 35
Epigenetic and Epigenomic Mechanisms Shape Sarcoma and Other Mesenchymal Tumor Pathogenesis
Bennani-Baïti, I. M. (2011) · Epigenomics · doi:10.2217/epi.11.93 · Cited by 32
Li, H., Song, F., Chen, X., Li, Y., Fan, J., & Wu, X. (2014) · PubMed Central · Cited by 32
Bmi-1 overexpression as an efficient prognostic marker in patients with nonsmall cell lung cancer
Zhang, X., Tian, T., Sun, W., Liu, C., & Fang, X. (2017) · Medicine · doi:10.1097/md.0000000000007346 · Cited by 35
Sun, H., Qiao, W., Cui, M., Yang, C., Wang, R., Goltzman, D., Jin, J., & Miao, D. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3921 · Cited by 32
Tian, Y., Meng, L., Wang, Y., Li, B., Yu, H., Zhou, Y., Bui, T., Abraham, C., Li, A. H., Zhang, Y., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136774 · Cited by 32
Chen, M. H., Fu, L., Zhang, F., Yang, Y., & Wu, X. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119748 · Cited by 32
The Role of Stem Cell Factor SALL4 in Leukemogenesis
Gao, C., Kong, N. R., & Chai, L. (2011) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v16.i1-2.110 · Cited by 33
UBAP2L is a novel BMI1-interacting protein essential for hematopoietic stem cell activity
Bordeleau, M.-È., Aucagne, R., Chagraoui, J., Girard, S., Mayotte, N., Bonneil, É., Thibault, P., Pabst, C., Bergeron, A., Barabé, F., et al. (2014) · Blood · doi:10.1182/blood-2014-01-548651 · Cited by 33
Gfi-1 takes center stage in hematopoietic stem cells
Duan, Z., & Horwitz, M. S. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.003 · Cited by 32
Ganguli‐Indra, G., Wasylyk, C., Liang, X., Millon, R., Leid, M. E., Wasylyk, B., Abecassis, J., & Indra, A. K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005367 · Cited by 33
Navarro–Álvarez, N., Kondo, E., Kawamoto, H., Hassan, W. A. R. A., Yuasa, T., Kubota, Y., Seita, M., Nakahara, H., Hayashi, T., Nishikawa, Y., et al. (2010) · Cell Transplantation · doi:10.3727/096368910x508997 · Cited by 32
Chen, C., Chiou, S., Huang, C., Jan, C.-I., Lin, S., Tsai, M., & Lo, J. (2009) · Journal of Biomedical Science · doi:10.1186/1423-0127-16-100 · Cited by 32
The chromatin signature of pluripotent cells
Boyer, A. (2009) · StemBook · doi:10.3824/stembook.1.45.1 · Cited by 32
Yamashita, M., Hirohashi, Y., Torigoe, T., Kusumoto, H., Murai, A., Imagawa, T., & Sato, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146501 · Cited by 32
Wu, K. (2011) · PubMed · Cited by 32
E2f6 and Bmi1 cooperate in axial skeletal development
Courel, M., Friesenhahn, L., & Lees, J. A. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21516 · Cited by 34
Gialmanidis, I. P., Bravou, V., Petrou, I., Kourea, H. P., Mathioudakis, A. G., Lilis, I., & Papadaki, H. H. (2013) · Lung · doi:10.1007/s00408-013-9490-4 · Cited by 32
Loss of AML1/Runx1 accelerates the development of MLL-ENL leukemia through down-regulation of p19ARF
Nishimoto, N., Arai, S., Ichikawa, M., Nakagawa, M. M., Goyama, S., Kumano, K., Takahashi, T., Kamikubo, Y., Imai, Y., & Kurokawa, M. (2011) · Blood · doi:10.1182/blood-2010-10-315440 · Cited by 31
Clinical significance of cell cycle inhibitors in hepatocellular carcinoma
Matsuda, Y., Wakai, T., Kubota, M., Takamura, M., Yamagiwa, S., Aoyagi, Y., Osawa, M., Fujimaki, S., Sanpei, A., Genda, T., et al. (2013) · Medical Molecular Morphology · doi:10.1007/s00795-013-0047-7 · Cited by 31
The ups and downs of p53 regulation in hematopoietic stem cells
Abbas, H. A., Pant, V., & Lozano, G. (2011) · Cell Cycle · doi:10.4161/cc.10.19.17721 · Cited by 33
Chang, B., Su, L., He, Q., Liu, Z., Zhao, L., Zhao, T., & Wang, A. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.08.005 · Cited by 31
González‐Gil, C., Ribera, J., Ribera, J., & Genescà, E. (2021) · Genes · doi:10.3390/genes12010079 · Cited by 32
Stark, V. A., Facey, C. O. B., Viswanathan, V., & Boman, B. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031424 · Cited by 31
Lv, D., Chen, L.-Y., Du, L., Zhou, L., & Tang, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.691410 · Cited by 32
Yu, J. J., Shen, C., Lin, M., Chen, X., Dai, X., Li, Z., Wu, Y., Fu, Y., Lv, J., Huang, X., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.70441 · Cited by 31
Zhou, Z.-H., Ping, Y., Yu, S., Liang, Y., Yao, X., Chen, J., Cui, Y., & Bian, X. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.033 · Cited by 31
Bmi1 in development and tumorigenesis of the central nervous system
Shakhova, O., Leung, C., & Marino, S. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0682-0 · Cited by 32
Harada, Y., Inoue, D., Ding, Y., Imagawa, J., Doki, N., Matsui, H., Yahata, T., Matsushita, H., Ando, K., Sashida, G., et al. (2013) · Blood · doi:10.1182/blood-2012-06-434423 · Cited by 32
Treanor, L. M., Volanakis, E. J., Zhou, S., Lu, T., Sherr, C. J., & Sorrentino, B. P. (2011) · Blood · doi:10.1182/blood-2010-09-309831 · Cited by 32
Chatoo, W., Abdouh, M., Duparc, R.-H., & Bernier, G. (2010) · Stem Cells · doi:10.1002/stem.462 · Cited by 32
Cav-1 deletion impaired hematopoietic stem cell function
Bai, L., Shi, G., Zhang, L., Guan, F., Ma, Y., Li, Q., Cong, Y.-S., & Zhang, L. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.105 · Cited by 31
Stem cell factor SALL4, a potential prognostic marker for myelodysplastic syndromes
Wang, F., Guo, Y., Chen, Q., Yang, Z., Ning, N., Zhang, Y., Xu, Y.-G., Xu, X., Tong, C., Chai, L., et al. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-73 · Cited by 31
Tumor suppressor mechanisms in immune aging
Liu, Y., & Sharpless, N. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.011 · Cited by 31
BM stem cells and cardiac repair: Where do we stand in 2004?
Orlic, D. (2005) · Cytotherapy · doi:10.1016/s1465-3249(05)70784-2 · Cited by 31
Sugihara, E., Shimizu, T., Kojima, K., Onishi, N., Kai, K., Ishizawa, J., Nagata, K., Hashimoto, N., Honda, H., Kanno, M., et al. (2011) · Oncogene · doi:10.1038/onc.2011.462 · Cited by 30
BMI1 attenuates etoposide-induced G2/M checkpoints via reducing ATM activation
Wei, F., Ojo, D., Lin, X., Wong, N., He, L., Yan, J., Xu, S., Major, P. P., & Tang, D. (2014) · Oncogene · doi:10.1038/onc.2014.235 · Cited by 32
Association between Bmi1 and clinicopathological status of esophageal squamous cell carcinoma
He, X., Cao, X., Ji, L., Zhu, B., Lv, J., Wang, D., Lu, P., & Cui, H.-G. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2389 · Cited by 30
Zhang, Q., Li, J., Li, Y., Che, H., Chen, Y., Dong, J., Xian, C. J., Miao, D., Wang, L., & Ren, Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15528 · Cited by 30
RUNX3 in Stem Cell and Cancer Biology
Chuang, L. S. H., Matsuo, J., Douchi, D., Mawan, N. A., & Ito, Y. (2023) · Cells · doi:10.3390/cells12030408 · Cited by 30
Markers in normal and cancer stem cells
Natarajan, T. G., & Fitzgerald, K. T. (2007) · Cancer Biomarkers · doi:10.3233/cbm-2007-34-506 · Cited by 30
B-lymphocyte commitment: Identifying the point of no return
Welinder, E., Åhsberg, J., & Sigvardsson, M. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.08.005 · Cited by 30
Yong, A. S. M., Stephens, N., Weber, G., Yixin, L. I., Savani, B. N., Eniafe, R. B., Keyvanfar, K., Kurlander, R. J., Rezvani, K., & Barrett, A. J. (2011) · Leukemia · doi:10.1038/leu.2010.325 · Cited by 31
Feeding the fire: the role of defective bone marrow function in exacerbating thymic involution
Dudakov, J. A., Khong, D., Boyd, R. L., & Chidgey, A. P. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.02.002 · Cited by 31
Neural stem cell self‐renewal requires the Mrj co‐chaperone
Watson, E. D., Mattar, P. A., Schuurmans, C. J., & Cross, J. C. (2009) · Developmental Dynamics · doi:10.1002/dvdy.22088 · Cited by 30
Pancreatic cancer stem cells and relevance to cancer treatments
Bednar, F., & Simeone, D. M. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22093 · Cited by 30
Baxter, P. A., Qi, L., Mao, H., Kogiso, M., Zhao, X., Liu, Z., Huang, Y., Voicu, H., Gurusiddappa, S., Su, J. M. F., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0160-4 · Cited by 32
MAPKAP kinase MK2 maintains self‐renewal capacity of haematopoietic stem cells
Schwermann, J., Rathinam, C., Schubert, M., Schumacher, S., Noyan, F., Koseki, H., Kotlyarov, A., Klein, C., & Gaestel, M. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.100 · Cited by 30
Exploitation of stem cell plasticity
Martin‐Rendon, E., & Watt, S. M. (2003) · Transfusion Medicine · doi:10.1111/j.1365-3148.2003.00462.x · Cited by 30
Integrative molecular and developmental biology of adult stem cells
Bunting, K. D., & Hawley, R. G. (2003) · Biology of the Cell · doi:10.1016/j.biolcel.2003.10.001 · Cited by 30
von Drygalski, A., Alespeiti, G., Ren, L., & Adamson, J. W. (2004) · Stem Cells and Development · doi:10.1089/154732804773099308 · Cited by 30
Fine-tuning the ubiquitin code at DNA double-strand breaks: deubiquitinating enzymes at work
Citterio, E. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00282 · Cited by 30
Polycomb repressive complex 2 (PRC2) suppresses Eμ-myc lymphoma
Lee, S. C.-W., Phipson, B., Hyland, C. D., Leong, H. S., Allan, R. S., Lun, A. T. L., Hilton, D. J., Nutt, S. L., Blewitt, M. E., Smyth, G. K., et al. (2013) · Blood · doi:10.1182/blood-2013-02-484055 · Cited by 29
Ohno, Y., Yasunaga, S., Ohtsubo, M., Mori, S., Tsumura, M., Okada, S., Ohta, T., Ohtani, K., Kobayashi, M., & Takihara, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011054107 · Cited by 29
Epigenetic Modifiers in Normal and Malignant Hematopoiesis
Haladyna, J. N., Yamauchi, T., Neff, T., & Bernt, K. M. (2015) · Epigenomics · doi:10.2217/epi.14.88 · Cited by 30
Ring1A and Ring1B inhibit expression of Glis2 to maintain murine MOZ-TIF2 AML stem cells
Shima, H., Takamatsu-Ichihara, E., Shino, M., Yamagata, K., Katsumoto, T., Aikawa, Y., Fujita, S., Koseki, H., & Kitabayashi, I. (2018) · Blood · doi:10.1182/blood-2017-05-787226 · Cited by 29
Aging and leukemic evolution of hematopoietic stem cells under various stress conditions
Kurosawa, S., & Iwama, A. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-020-00138-3 · Cited by 29
The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies
Maksoud, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02915-2 · Cited by 29
Xu, N., Li, Y.-L., Zhou, X., Cao, R., Li, H., Lu, Q., Li, L., Lu, Z., Huang, J., Sun, J., et al. (2015) · Journal of Cancer · doi:10.7150/jca.11959 · Cited by 29
Balasubramanian, S., Lee, K., Adhikary, G., Gopalakrishnan, R., Rorke, E. A., & Eckert, R. L. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00071.x · Cited by 29
Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors
Kumamoto, H., & Ohki, K. (2009) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2009.00807.x · Cited by 30
Wang, Y., Lv, H., Xu, Z., Sun, J., Ni, Y., Chen, Z., & Cheng, X. (2019) · Scientific Reports · doi:10.1038/s41598-018-36940-w · Cited by 29
Non-Canonical Functions of the ARF Tumor Suppressor in Development and Tumorigenesis
Lаgopati, N., Belogiannis, K., Angelopoulou, A., Papaspyropoulos, A., & Gorgoulis, V. G. (2021) · Biomolecules · doi:10.3390/biom11010086 · Cited by 30
Stricker, T. P., & KUMAR, V. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0792-2.50012-2 · Cited by 28
Idiopathic myelofibrosis: pathogenesis to treatment
Reilly, J. T. (2006) · Hematological Oncology · doi:10.1002/hon.771 · Cited by 29
Clarke, M. F., & Hass, A. T. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200300130 · Cited by 29
Self-citationThe roles of Polycomb group proteins in hematopoietic stem cells and hematological malignancies
Takamatsu-Ichihara, E., & Kitabayashi, I. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-2011-5 · Cited by 28
Fucito, A., Lucchetti, C., Giordano, A., & Romano, G. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.10.018 · Cited by 29
Bmi-1 Absence Causes Premature Brain Degeneration
Cao, G., Gu, M., Zhu, M., Gao, J., Yin, Y., Marshall, C., Xiao, M., Ding, J., & Miao, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032015 · Cited by 30
Xü (2009) · Molecular Medicine Reports · doi:10.3892/mmr_00000170 · Cited by 28
Biphasic MLL takes helm at cell cycle control: Implications in human mixed lineage leukemia
Liu, H., Takeda, S., Cheng, E. H. Y., & Hsieh, J. J.-D. (2008) · Cell Cycle · doi:10.4161/cc.7.4.5426 · Cited by 28
Fish Oil–Rich Diet Promotes Hematopoiesis and Alters Hematopoietic Niche
Xia, S., Li, X.-P., Lu, C. Y., Han, M., Zhang, M.-M., Shao, Q., Hua-xi, X., & Qi, L. (2015) · Endocrinology · doi:10.1210/en.2015-1258 · Cited by 28
Stem Cell Biology: A View toward the Future
Lemischka, I. R. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1349.017 · Cited by 28
Cho, J. S., Kook, S. H., Robinson, A. R., Niedernhofer, L. J., & Lee, B.-C. (2013) · Stem Cells · doi:10.1002/stem.1261 · Cited by 27
Cancer stem cells and therapeutic targets: an emerging field for cancer treatment
Vaz, A. P., Ponnusamy, M. P., & Batra, S. K. (2012) · Drug Delivery and Translational Research · doi:10.1007/s13346-012-0095-x · Cited by 29
Epigenetics of T cells regulated by Polycomb/Trithorax molecules
Onodera, A., & Nakayama, T. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.03.001 · Cited by 27
Unraveling the molecular components and genetic blueprints of stem cells
Li, L., & Akashi, K. (2003) · BioTechniques · doi:10.2144/03356ss02 · Cited by 27
Xu, F., Li, X., Liu, L., Xu, X., Zhang, L., Zhang, S., Lin, P., Wang, X., Wang, Y., & Li, Q. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4763 · Cited by 27
Epigenetic Reprogramming and Emerging Epigenetic Therapies in CML
Bugler, J., Kinstrie, R., Scott, M. T., & Vetrie, D. L. P. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00136 · Cited by 28
Ikonomi, N., Werle, S. D., Schwab, J. D., & Kestler, H. A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00848 · Cited by 29
Gairola, K., Gururani, S., Bahuguna, A., Garia, V., Pujari, R., & Dubey, S. K. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13772 · Cited by 27
Rouhi, L., Ferreiro, J. F., Put, N., Michaux, L., Tousseyn, T., Lefebvre, C., Gardiner, A. C., Kelver, W. D., Demuynck, H., Verschuere, J., et al. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22088 · Cited by 28
Metadata
- Authors
- Park, I.-K., Qian, D., Kiel, M., Becker, M. W., Pihalja, M., Weissman, I. L., Morrison, S. J., & Clarke, M. F.
- Affiliations
- University of Michigan (US)
- Howard Hughes Medical Institute (US)
- Stanford Medicine (US)
- Corresponding author
- Clarke, Michael F.
- ORCID
- Venue
- Nature
- Published
- 2003-04-20
- Volume
- 423
- Issue
- 6937
- Pages
- 302-305
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2021050536
- Cited by
- 1,871
- References
- 31
- Citations by year
- 2026: 16 · 2025: 19 · 2024: 15 · 2023: 29 · 2022: 50 · 2021: 48 · 2020: 45 · 2019: 51 · 2018: 52 · 2017: 68 · 2016: 79 · 2015: 81 · 2014: 97 · 2013: 100 · 2012: 127
- FWCI
- 55.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- University of Michigan
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- BMI1, hematopoietic stem cells, self-renewal, stem cell maintenance, p16INK4a, p19ARF, p53-dependent cell death, growth arrest, cell survival genes, hematopoiesis, bone marrow
- MeSH terms
- Proto-Oncogene Mas, Animals, Bone Marrow Cells, Cell Division, Gene Expression Regulation, Hematopoietic Stem Cells, Humans, Liver, Models, Biological, Nuclear Proteins, Proto-Oncogene Proteins, Repressor Proteins, RNA, Messenger, Bone Marrow Transplantation, Gene Deletion, Hematopoietic Stem Cell Transplantation, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Protein p14ARF, Mice, Polycomb Repressive Complex 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review